DRG 949 Overview

DRG 949 covers inpatient stays classified as Aftercare with Complication or Comorbidity or Major Complication or Comorbidity, generally involving encounters for continued postoperative or post-treatment care rather than new primary procedures. Typical cases include management of surgical dressings, removal of devices, or follow-up care for complications that require an inpatient setting. This Diagnosis-Related Group matters for Medicare payment because it groups aftercare resource use separately from initial surgical admissions and influences reimbursement levels tied to the presence of Complication or Comorbidity or Major Complication or Comorbidity.

• Studies on optimizing transition-of-care protocols for patients requiring ongoing medical or nursing care after an acute hospitalization: these trials compare structured multidisciplinary discharge programs (including early rehabilitation, medication reconciliation, and coordinated home health services) versus standard discharge planning among patients admitted for conditions that necessitate aftercare with complicating comorbidities. The patient population typically includes older adults or medically complex patients with functional decline, multimorbidity, or recent major procedures who require continued skilled services; outcomes measured include readmission rates, functional status, and resource utilization. This research is relevant to providers and payers because improving transitions can reduce costly readmissions and length of stay in post-acute settings while aligning care intensity with patient needs.
• Comparative effectiveness research evaluating intensity and setting of post-acute care for patients with complications or comorbid conditions: trials and observational studies assess outcomes for similar patients discharged to different levels of care (skilled nursing facility, inpatient rehabilitation, hospital-based observation, or enhanced home health) and compare aggressive therapy versus conservative management. The focus population comprises patients classified under aftercare with CC/MCC who have high-risk features—such as significant functional impairment, wound care needs, or complex IV therapies—where the optimal site and intensity of ongoing care is uncertain. Findings inform provider decisions about care sequencing and payer policies around authorization, bundled payments, and appropriate use criteria by demonstrating which settings and therapy intensities yield better functional recovery, lower costs, and fewer complications.
• Prospective observational and interventional studies on management of medical complexity during extended recovery periods, including monitoring, complication prevention, and care coordination strategies: these studies evaluate protocols for surveillance of common complications (eg, infections, device-related issues, medication adverse events) and integration of case management or telehealth follow-up for patients with CC/MCC-level needs after discharge. They enroll patients with sustained care needs after an index hospitalization—often elderly patients with multiple chronic conditions or those requiring ongoing wound, ostomy, or ventilator care—and measure outcomes such as complication rates, emergency department visits, long-term functional outcomes, and cost-effectiveness. This area is crucial for payers and providers because reducing downstream complications and efficiently managing complex needs can lower overall costs while improving patient safety and long-term outcomes.